谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Time Limited Exposure to a ROR1 Targeting Bispecific T Cell Engager (NVG-111) Leads to Durable Responses in Subjects with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)

William Townsend,Sarah Leong,Mittal Shah,Toby Batten,David Tucker,Bryson Pottinger,Shankaranarayana Paneesha,Dima El-Sharkawi,Toby A. Eyre,Ho Pui Jeff Lam,Jiexin Zheng,Sarah Cook,David Granger,David Ahern,Kieran O'Donovan,Amit C. Nathwani,Parag Jasani

BLOOD（2023）

引用 0|浏览11
暂无评分
关键词
T Cell Therapy,Tumor Regression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要